R&G PharmaStudies(301333.SZ) shareholder Harmony Growth Phase II and Harmony Health have collectively reduced their holdings by 2.1262 million shares.

R&G PharmaStudies (301333.SZ) announced that the company has received a notification letter from Harmony Growth Phase II and Harmony Health stating the implementation status of the reduction plan upon its completion. The above-mentioned shareholders collectively reduced their holdings of the company's shares by 2.1262 million shares.